Summary
PharmAthene, Inc. (PharmAthene) is a pharmaceutical company that develops and commercializes medical counter measures to biological and chemical weapons. The company offers products such as recombinant protective antigen anthrax vaccine, human monoclonal antibody antitoxin and recombinant BChE bioscavenger. Its products are used for treatment of anthrax, and nerve agent poisoning. PharmAthene serves in markets of biodefense, US civilian, military, and non-US markets. The company collaborates with various pharma and research companies across the world. It markets its products through its distributors across the world. PharmaAthene is headquartered in Annapolis, Maryland, the US.
PharmAthene, Inc. (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
PharmAthene, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deal Details 10
Merger 10
Pharmathene Terminates Merger With Theraclone Sciences 10
Licensing Agreements 12
Immunovaccine Enters into Licensing Agreement with PharmAthene 12
PharmAthene Enters Into Licensing Agreement With Percivia For PER.C6 Cell Line 13
PharmAthene Terminates Licensing Talks With Siga Technologies 14
Equity Offering 15
PharmAthene to Raise Additional USD30 Million in Public Offering of Shares 15
PharmAthene Completes Registered Direct Offering Of US$6.5 Million 16
PharmAthene Completes Over-Allotment Option Of Registered Public Offering For US$17.3 Million 18
PharmAthene Completes Registered Direct Offering Of US$3.9 Million 20
PharmAthene Completes Registered Direct Offering Of US$2.5 Million 22
PharmAthene, Inc. - Key Competitors 24
Key Employees 25
Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List of Tables
PharmAthene, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
PharmAthene, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
PharmAthene, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Pharmathene Terminates Merger With Theraclone Sciences 10
Immunovaccine Enters into Licensing Agreement with PharmAthene 12
PharmAthene Enters Into Licensing Agreement With Percivia For PER.C6 Cell Line 13
PharmAthene Terminates Licensing Talks With Siga Technologies 14
PharmAthene to Raise Additional USD30 Million in Public Offering of Shares 15
PharmAthene Completes Registered Direct Offering Of US$6.5 Million 16
PharmAthene Completes Over-Allotment Option Of Registered Public Offering For US$17.3 Million 18
PharmAthene Completes Registered Direct Offering Of US$3.9 Million 20
PharmAthene Completes Registered Direct Offering Of US$2.5 Million 22
PharmAthene, Inc., Key Competitors 24
PharmAthene, Inc., Key Employees 25
PharmAthene, Inc., Subsidiaries 26
List of Figures
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
PharmAthene, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8